Active Molecules (270)
InChIKey pChEMBL Type Targets Clinical
RIAXXCQKICATHW 6.5 IC50 8
AFLMEDYILBVTLD 6.5 IC50 7
CUVGUPIVTLGRGI 6.4 IC50 7
XOTFPBSIGVOVNZ 6.4 IC50 7
BFMVLFRBLSHGFU 6.4 Ki 7
IWBBGNZPEIAVFV 6.4 IC50 7
JHKKCDOQENTIHK 6.4 Ki 7
PDWIXUPKLCRNMD 6.4 Ki 7
YYRFNNUNFMRYPC 6.4 Ki 7
TYILUFWHLUDPEG 6.4 IC50 2
ZNNQFFKFWSWODG 6.4 IC50 6
ZRBNLIHXVISUQQ 6.4 IC50 7
LWFDMVFVKWWYFN 6.3 IC50 7
MYDMWESTDPJANS 6.3 IC50 8
RARPYAVALSABGF 6.3 IC50 7
XFAHIODKMNWZPL 6.3 IC50 7
ZAAIRIXWNJOFIN 6.3 IC50 7
FTBHFNJYFXSJEB 6.3 IC50 7
JAQUASYNZVUNQP 6.3 Ki 9
CJTFFAPMDBAOOA 6.3 IC50 8
MSXJZHUTIDWQBZ 6.3 IC50 8
AJNXCTFYCKDBPU 6.3 IC50 8
BUGYDGFZZOZRHP 6.3 IC50 8
DHJQWBSZKBDBFP 6.3 IC50 7
VEZHNUFFLDDMFJ 6.3 IC50 7
FWUQWDCOOWEXRY 6.2 Ki 7
FIMZTNSDXIYRNP 6.2 IC50 7
HCZMRRZYIBUPSV 6.2 Ki 9
ZZKJOINTECJJPA 6.2 IC50 4
QLNADLCRRYZRHE 6.2 IC50 2
OVQNSGBYKOJYBK 6.2 Ki 7
QJEFKTCXLNVCHX 6.2 IC50 7
SGEHBQYHDGXTNO 6.2 IC50 5
ZPEIMTDSQAKGNT 6.2 IC50 35 Yes
MKXZASYAUGDDCJ 6.2 Ki 10
CSKHLMXZMHQWGD 6.2 IC50 7
IESYTBDOVCIPKA 6.2 IC50 7
AEOIZSSKEQUNLG 6.2 IC50 7
UHDMAEPGMOIEHH 6.2 IC50 7
DRQCXUHOMAEZPG 6.2 Ki 7
UIRMNVOEQMAKFM 6.2 IC50 7
YVDZNYZIFGWCEP 6.2 IC50 7
UHDMAEPGMOIEHH 6.2 IC50 7
LFUXIUBCWODHDF 6.1 Ki 7
WFTLZGPAIOZPTP 6.1 IC50 7
XDRYMKDFEDOLFX 6.1 IC50 13
QBBWPKXOBZOZFR 6.1 IC50 2
LEAZEMHYRVKZDA 6.1 IC50 7
SOFHJXSQCMUXKH 6.1 Ki 7
GXQNTGVRQAAYQI 6.1 IC50 7
2D structure